Related Experiment Video

Updated: Mar 21, 2026

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein
07:29

Cell-free Biochemical Fluorometric Enzymatic Assay for High-throughput Measurement of Lipid Peroxidation in High Density Lipoprotein

Published on: October 12, 2017

9.8K

Roles of High-Density Lipoprotein Cholesterol in Patients With Acute Myocardial Infarction

Cheol Hyun Lee1, Jong Shin Woo, Chang Bum Park

  • 1From the Department of Internal Medicine, Division of Cardiology, Kyung Hee University Hospital, Kyung Hee University School of Medicine, Seoul (CHL, JSW, CBP, JMC, JK, WK); Department of Medicine, Division of Cardiology, Chonnam National University Hospital, Gwangju, Korea (YKA, MHJ).

Medicine
|May 6, 2016
PubMed

Insights

High-density lipoprotein cholesterol (HDL-C) levels impact cardiovascular outcomes in acute myocardial infarction (AMI) patients. Maintaining or increasing HDL-C is associated with better 12-month major adverse cardiac events (MACEs) rates.

Area of Science:

  • Cardiology
  • Clinical Research
  • Biochemistry

Background:

  • High-density lipoprotein cholesterol (HDL-C) is traditionally viewed as a protective factor against cardiovascular disease.
  • Recent clinical trials have yielded discouraging results regarding therapies aimed at raising HDL-C levels in patients already on statin therapy.
  • The complex relationship between HDL-C and cardiovascular outcomes requires further investigation.

Purpose of the Study:

  • To investigate the association between follow-up high-density lipoprotein cholesterol (HDL-C) levels and clinical outcomes in patients who have experienced acute myocardial infarction (AMI).
  • To determine the relationship between changes in HDL-C levels and the occurrence of major adverse cardiac events (MACEs) within 12 months post-AMI.

Main Methods:

  • Analysis of 3574 patients with AMI from the Korea Acute Myocardial Infarction Registry (KAMIR) with available follow-up HDL-C data.
  • Stratification of patients into groups based on initial HDL-C levels and changes in HDL-C over time.
  • Multivariate analysis to assess the predictive value of HDL-C levels for cardiovascular events after adjusting for confounding variables.

Main Results:

  • Patients with initial HDL-C ≥ 40 mg/dL exhibited significantly lower 12-month MACE rates, including cardiac and all-cause mortality.
  • Decreasing HDL-C levels were associated with significantly higher 12-month MACE rates, comparable to those with increasing HDL-C.
  • Multivariate analysis confirmed HDL-C level as a significant predictor of cardiovascular events (HR, 1.38; 95% CI, 1.12-1.71).

Conclusions:

  • Follow-up changes in high-density lipoprotein cholesterol (HDL-C) levels are significantly associated with cardiovascular outcomes in patients with acute myocardial infarction (AMI).
  • The study highlights the dynamic relationship between HDL-C levels and cardiovascular risk, emphasizing the importance of monitoring HDL-C changes post-AMI.

More Related Videos

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy07:40

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy

Published on: May 26, 2023

1.7K
Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles09:15

Differential Effects of Lipid-lowering Drugs in Modulating Morphology of Cholesterol Particles

Published on: November 10, 2017

15.2K

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
431
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
837
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
571
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
408
Lipid-Lowering Drugs: Statins and Miscellaneous Agents01:20

Lipid-Lowering Drugs: Statins and Miscellaneous Agents

Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
1.7K
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
409